Education
About Us
Working with TipRanks
Follow Us
Steven Quay Insider Profile
4 Followers
Steven Quay, President & CEO, Director at Atossa Therapeutics, holds 36.15K shares in Atossa Therapeutics (Ticker: ATOS). Most recently, Steven Quay Bought $11,239 shares of Atossa Therapeutics on May 22, 2025 for an estimated value of 9.78K.
Steven Quay Atossa Therapeutics (ATOS)President & CEO, Director
Atossa Therapeutics (ATOS)
President & CEO, Director
Ranked #95,809 out of 102,830 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-56.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Steven Quay holds in companies
Most Profitable Insider Trade
The most profitable trade made by Steven Quay
Steven Quay's Trading History
List of latest transactions for each holding click on a transaction to see Steven Quay's performance on stock
You May Also Like
Steven Quay insider profile FAQ
What is the percentage of profitable transactions made by Steven Quay?
The percentage of profitable transactions made by Steven Quay is 0%.
What is the average return per transaction made by Steven Quay?
The average return per transaction made by Steven Quay is -56.80%.
What stocks does Steven Quay hold?
Steven Quay holds: ATOS stocks.
What was Steven Quay’s latest transaction?
Steven Quay latest transaction was an Informative Buy of $9.78K.
What was Steven Quay's most profitable transaction?
Steven Quay’s most profitable transaction was an Informative Buy of ATOS stock on May 22, 2025. The return on the trade was -5.20%.
What is Steven Quay's role in Atossa Therapeutics?
Steven Quay's role in Atossa Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.